Shea and Shawn Guillorys journey to parenthood has been a complex one thats been characterized by high peaks and low valleys. Along their journey, the Georgia couple lost a set of twins at 19 weeks gestation, an ordeal that almost claimed Guillory as a victim of maternal mortality. The experience was devastating and discouraging to the pairs dream of starting a family. But then, something magical happened. The Guillorys conceived another set of twins and welcomed them into the world.
The birth of rainbow babies Sawyer and Saxton made the corporate tech investor and her husband ecstatically happy, but a plot twist was quickly introduced to their happily ever after. One of the twins, Sawyer, was diagnosed with sickle cell disease (SCD), a hereditary blood disorder that affects one out of every 365 Black or African American births in the United States, just weeks after he was born. It was a really gut-wrenching blow, Guillory says, reflecting on her infant sons diagnosis five years ago. I was in denial, at first. I was devastated. I didnt want to believe it, Guillory, the founder of non-profit organization Sawyers Sickle Circle, tells EBONY. I blamed myself. I blamed my husband because he didnt know that he carried the trait. While Guillory knew that she had sickle beta plus thalassemia (a type of sickle cell disease that affects hemoglobin), her husband was unaware that he was a carrier of the sickle cell trait. Although the pair discussed the possibility of him also carrying the trait after meeting at Georgia State University and beginning their dating relationship, they never circled back to it, she explains.
After receiving Sawyers diagnosis, Guillory asked her childrens pediatrician where she would seek treatment if her own son had been diagnosed with sickle cell disease, which led her to the Aflac Cancer and Blood Disorders Center of Childrens Healthcare of Atlanta.
Theyve been a part of our journey since the very beginning, says Guillory, who immediately began to scour the internet for any helpful information she could find about sickle cell disease and later took her findings back to Sawyers medical team. I was so concerned. I felt like I was being given a death sentence for my son and the only thing that I could think about was life, life, life, and living. Wheres the cure? Thats what drove my research.
It was through her research that she learned a bone marrow transplant from a closely matching donor could potentially cure Sawyer of the disorder. From there, she immediately began advocating for doctors to consider performing the procedure on Sawyer, hopeful that his twin brother, Saxton, would be a match. I went back armed with information. I shared what I read with the doctors, who listened, Guillory recalls. The physicians presented other options and warned of the potential complications and side effects of a bone marrow transplant, providing the twins mom with a complete set of data and info so she could make the best-informed decision for her child. After reviewing the options and the pros and cons, Guillory decided that the bone marrow transplant was the best option for her Sawyerso the twins immediately underwent testing to determine if they were a match. What took days felt like it took weeks and months, says their mom. When the news finally came through that Saxton was a match, it was delivered personally by the centers hematologist.
I literally dropped to my knees and thanked her and started thanking God. I felt like a weight had been lifted from my shoulders. I felt so bad because my son had something that was passed down from me and his father. Even though we gave him life, my son had something that could literally take him out of here, recalls Guillory. The individual that he was born with in my womb would be his saving grace. My son was literally the cure for his brother.
After nearly three years of treatment and testing, Saxton and Sawyer underwent a successful bone marrow transplant. As a mother, when youre wanting to get your child to the finish line, they gracefully held my hand, says Guillory of the team at the Aflac Cancer and Blood Disorders Center, who guided her and her family through the process.
Thankfully, for the Guillory family, The Aflac Cancer and Blood Disorders Center was able to help them and many more families across the country deal with such an arduous ordeal. For over 26 years, Aflac has remained committed to the sickle cell disease community by providing wraparound support to children stricken by this painful illness and to their families. The sickle cell disease program at the Aflac Cancer and Blood Disorders Center is the largest pediatric program in the United Stateson average, the center cares for 2,000 patients annually. The company has donated more than $6 million to the program. Plus last year, the Aflac Cancer and Blood Disorders Center was named a Top 10 Best Pediatric Cancer Program by U.S. News and World Report, and it ranked number one in the nation for total sickle cell disease discharges. Aflac aims to shine a light on sickle cell disease and advance health equity and education as it relates to sickle cell disease in all communities.
As a sign of its commitment to bringing public awareness to this debilitating illness that largely affects communities of colorand especially those within the African American communitythis past June, for World Sickle Cell Day, Aflac launched the #AflacSickleCellSense campaign, a social media campaign, which will run through September that aims to start and drive conversations surrounding sickle cell disease as a societal issue. Knowledge is power. We need to talk about this issue, says Guillory. Its something we should speak about all of the time because [its] in our livesits every day. Another way that Aflac is keeping the conversation going is through the Aflac x EBONY Community Connect webinar, slated to take place on Sept. 30th, and which will feature panelists and experts who will broaden awareness and discuss the impact of sickle cell disease on the Black community-at-large and what can be done to lessen it.
Additionally, Aflac has moved to expand its award-winning My Special Aflac Duck program to offer supplemental social-emotional support for children living with sickle cell disease. The robotic comforting duck, which was originally introduced to support children with cancer, will be distributed at the start of 2022 to kids above the age of three with sickle cell disease, free of charge. The new version of the My Special Aflac Duck will be tailored to meet the unique emotional needs of sickle cell patients and their caregivers. Theyve created something really special, Guillory says of the soothing duck. Its great for kids who may be introverts or like, my kids were very young and had a hard time expressing themselves. It comes with a blanket. It comes with an app where you can give it water. You can give it medicine and thats really important. Through a pilot program at the Aflac Cancer and Blood Disorders Center, which first introduced the ducks to more than 100 sickle cell patients in 2020, families shared with researchers that the ducks helped soothe the emotional stress that sickle cell disease imparts on children. When my son needed to express himself but didnt know how to do so verbally, he was able to use the duck, shares Guillory. Further, the duck helped during the pandemic since the boys were spending a lot of time away from each other and Saxton could no longer join Sawyer for doctors appointments.
As mentioned above, sickle cell disease largely impacts communities of color, especially Blacks and African Americans. Below are a few answers to address the common concerns and questions on how the illness largely affects our community.
What is sickle cell disease?
Sickle cell disease causes red blood cells to become crescent-shaped. The awkward shape of the blood cells, paired with the fact that they are hard and sticky, causes them to clump together; thus, hindering oxygen flow to the rest of the body. According to Stanford Childrens Health, once cells clump together, the blockage causes pain and can even cause damage to major organs.
While sickle cell disease also impacts people of South American, Caribbean, Central American, and Saudi Arabian ancestry, it disproportionately affects African-Americans.
How do people get sickle cell disease?
Sickle cell disease is passed from parent to child. As explained by the CDC, If both parents have the sickle cell trait, there is a 25% chance that the child will have sickle cell disease.
What are the symptoms of sickle cell disease?
According to the Mayo Clinic, common symptoms of sickle cell disease include episodes of severe pain, anemia, fatigue, swelling of hands and feet, recurring infections, impaired vision, stunted growth, and delayed puberty.
Is there a cure for sickle cell disease?
Presently, one cure for sickle cell disease is available, which is a bone marrow transplant. The Aflac Cancer and Blood Disorders Center is one of the largest transplant centers in the nation. However, like most other transplant procedures, one of the many obstacles to having this procedure is finding a willing donor who has a closely matching bone marrow. When a stem cell transplant is not an option, as explained by Sophie Lanzkron for Johns Hopkins Medicine, physicians often prescribe strong opioids to mask the pain brought on by crisis episodes.As it stands, there are two other FDA-approved medications for managing sickle cell disease and both have been proven to prevent those painful episodes.
Why is sickle cell disease still a problem in this day and age?
Sickle cell disease was first identified in a patient in 1910. Despite this discovery being more than 100 years old, limited funding and awareness of this hereditary disease persist. A variety of factors contribute to the lack of understanding of sickle cell disease; however, a primary driver that keeps physicians in the dark is limited funding for research. In order to truly move the needle, groups that are not primarily affected by sickle cell disease will have to join the rallying cry for change.
What can I do to help?
There are many ways that people can join the fight to eradicate sickle cell disease. A great place to start is by educating yourself on the illness by reading literature and joining informative conversations such as the Aflac x EBONY Community Connect webinar on Sept. 30.
You can also donate to vetted charities and research funds with a focus on supporting those living with sickle cell disease. Or, join a bone marrow donor registry, which can help to match you with sickle cell disease patients who are in dire need of a transplant. Lastly, you can make genetic testing a part of your family planning process to determine if you and your partner both possess the sickle cell trait.
For more information about Aflacs commitment to sickle cell disease, visit http://www.aflac.com/sicklecell. You can also sign up here to receive an email when My Special Aflac Duck is available for children with sickle cell disease.
Read the original post:
- COVID-19: Researchers warn against overhyping early-stage therapies - Medical News Today - October 26th, 2021
- OpRegen Data Update to Be Featured at 2021 American Academy of Ophthalmology Annual Meeting in Presentation by Michael S. Ip, M.D. - Yahoo Finance - October 26th, 2021
- Insights & Outcomes: Place cells, planarians, and 'prewet' proteins - Yale News - October 26th, 2021
- IMAC Holdings The Back Space Announces the Completion of Two Additional Retail Spinal Care Locations - Yahoo Finance - October 26th, 2021
- JEFFERSON PARISH PARTNERS WITH LOUISIANA DEPARTMENT OF HEALTH TO ADMINISTER FREE FLU SHOTS AND COVID-19 VACCINES ON NOVEMBER 6, 2021 - 10-25-YYYY -... - October 26th, 2021
- Male Infertility Could Be Treated With Monkey Cells; New Study Shows How These Animals Could Help Address the Condition - Science Times - October 26th, 2021
- Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters in CLABSI Patients - Yahoo... - October 26th, 2021
- New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia - News-Medical.Net - October 25th, 2021
- Getting to Know Kate Roth at Beacon Integrative Medical Center in Rexburg - East Idaho News - October 25th, 2021
- Global Cell Therapy Market Report 2021-2028 - Growing Adoption of Regenerative Medicine & Introduction of Novel Platforms and Technologies -... - October 25th, 2021
- Vertex reports positive results for first patient in Type 1 diabetes trial - BetaBoston - October 23rd, 2021
- Morris receives grant for stem cell research - The Source - Washington University Record - October 23rd, 2021
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes - PMLiVE - October 23rd, 2021
- McLaughlin Research Institute receives $5 million gift to support neurology studies - Great Falls Tribune - October 23rd, 2021
- AML medication and treatment: What to know - Medical News Today - October 23rd, 2021
- U S Stem Cell : USRM to Focus on Animal Health and Lead Pet-Care Innovation - Marketscreener.com - October 19th, 2021
- Opinion: Why Colin Powell's death should not be framed as the death of a vaccinated person - Poynter - October 19th, 2021
- Quris combines AI with patient on a chip to speed drug development and reduce animal testing - TechCrunch - October 19th, 2021
- Dr. Helen Heslop elected to the National Academy of Medicine - Baylor College of Medicine News - October 19th, 2021
- Researchers report long-lasting effects of gene therapy in children with deadly immune disorder - News-Medical.Net - October 19th, 2021
- Coronavirus: How does misinformation spread, and how can we stop it? - The Jerusalem Post - October 17th, 2021
- Dr. Kahl on the Potential Utility of Frontline CAR T-Cell Therapy in MCL - OncLive - October 17th, 2021
- FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With Early Non-Small Cell Lung Cancer - Business Wire - October 17th, 2021
- Global Stem Cell and Primary Cell Culture Medium Market 2021 Trends and Leading Players Analysis 2027 Merck, STEMCELL Technologies, Irvinesci, Cell... - October 15th, 2021
- Dr. Erba on the Evolution of Treatment in MCL - OncLive - October 15th, 2021
- After no stem cell donors stepped up to saved her son, mom continues to help others facing the same challenge - Chicago Tribune - October 15th, 2021
- International ZIM Network: SmartMed - Regenerative Solutions for the Therapies of Tomorrow - Business Wire - October 15th, 2021
- Are 'robot massages' the future of muscle repair? - Medical News Today - October 15th, 2021
- What the FDA Panel's Moderna Booster Shot Vote Means and What's Next - NBC Chicago - October 15th, 2021
- Phase 2 Clinical Trial Data of NurOwn in Progressive MS Will Be Presented at the 37th Congress of the European Committee for Treatment and Research in... - October 15th, 2021
- R3 Stem Cell & Exosome Therapy: Joint & Back Pain, Avoid ... - October 13th, 2021
- Stem Cell PhD Program | Institute for Stem Cell Biology ... - October 13th, 2021
- New stem cell identified by Sanford Burnham Prebys researchers offers hope to people with rare liver disease - Newswise - October 13th, 2021
- Repurposed Drug Reverses Signs of Alzheimers in Mice, Human Cells - The Scientist - October 13th, 2021
- Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development - StreetInsider.com - October 13th, 2021
- What the latest COVID research says about breakthrough cases and transmission : Shots - Health News - NPR - October 13th, 2021
- HNF collaborates with Rarebase on a Drug Discovery Platform to develop treatments for Charcot-Marie-Tooth (CMT) - PRNewswire - October 13th, 2021
- Autologous HSCT Continues to Show Sustained Benefit in MCL, But Targeted Therapies May Challenge its Role as Standard Frontline Treatment -... - October 13th, 2021
- Bartolo Coln, Winner Of The Cy Young, Wins Lawsuit In Case Of Stem Cell Treatment To Which He Was Subjected Before His Return To The Major Leagues. -... - October 11th, 2021
- The Impact Of Market Restrictions On The US Stem Cell Biomaterials Market - Med Device Online - October 11th, 2021
- Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Letter. - Yahoo Finance - October 11th, 2021
- Top US Leukemia Experts from Academia, Industry and Public Sector Coming Together at Acute Myeloid Leukemia Conference on October 22 - OncLive - October 11th, 2021
- Precision medicine data dive shows water pill may be viable to test as Alzheimer's treatment - National Institutes of Health - October 11th, 2021
- Treating Early Relapse in Follicular Lymphoma - Targeted Oncology - October 11th, 2021
- Humans and Chimpanzees Use a Part of Their DNA in Different Ways - Technology Networks - October 11th, 2021
- A stem cell treatment for MS offers some patients hope. But is it hope that will last? - WHYY - October 9th, 2021
- CAR T Offer New Treatment Option for Non-Hodgkin Lymphoma - Targeted Oncology - October 9th, 2021
- FDA Advisory Committee Recommends Maribavir to Treat Cytomegalovirus CMV Infection and Disease - Contagionlive.com - October 9th, 2021
- What surgeons are saying about regenerative medicine in 2021 - Becker's Orthopedic & Spine - October 9th, 2021
- Study illuminates how BRD4 protein directs the spatial organization of DNA within cell nucleus - News-Medical.net - October 9th, 2021
- Cellular Therapy Strategies Offer the Prospect of Deep Remissions for Multiple Myeloma - OncLive - October 9th, 2021
- Anti-CD47 Therapy and Other New Approaches to the Treatment of Myelodysplastic - Targeted Oncology - October 9th, 2021
- ViaCyte to Present at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa - PRNewswire - October 7th, 2021
- Seattle Stem Cell Therapy Clinic - Seattle Sports Medicine ... - October 7th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - PRNewswire - October 7th, 2021
- New Stem Cell Approach Through Using Wavelength Laser Might have Discovered Why Humans Lose Hair - Tech Times - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - WMTV - NBC15 - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Northwesterns SPORE has made advances in understanding the genetic basis of glioblastoma - News-Medical.Net - October 5th, 2021
- NextCure Announces New Appointments to its Board of Directors - GlobeNewswire - October 5th, 2021
- Therapy and Prevention Strategies for Myocardial Infarction | IJN - Dove Medical Press - October 3rd, 2021
- Lack of awareness about blood stem cell donation is one of the leading causes for low number of donors in In.. - ETHealthworld.com - October 3rd, 2021
- Advanced technique offers new insights about the dynamics of gliomas - News-Medical.net - October 3rd, 2021
- "Stem cell-based therapeutics poised to become mainstream option - BSA bureau - October 2nd, 2021
- The stem cell revolution isnt what you think it is - New Scientist News - October 2nd, 2021
- Stem cell agency gives out $2 million a minute - Capitol Weekly - October 2nd, 2021
- Researching the Safety and Effectiveness of Stem Cells to Treat 'Long Covid' - Entrepreneur - October 2nd, 2021
- United States Regenerative Medicine Markets to 2026: Focus on Cell Therapies, Gene Therapies, Progenitor & Stem Cell Therapies, Tissue Engineered... - October 2nd, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 2nd, 2021
- Omeros Provides Regulatory Update on Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA - Business Wire - October 2nd, 2021
- Stem Cell Umbilical Cord Blood Market in North America 2021 Sees Growth Due to Rising Spending Capacity and Suitable Payment Plans - PRNewswire - October 2nd, 2021
- BrainStorm to Present Phase 2 Progressive MS Study Results in Oral Presentation at 37th Congress of ECTRIMS - BioSpace - October 2nd, 2021
- Macomics Announces New Hires that Expands its Macrophage-based Drug Discovery R&D Team - BioSpace - October 2nd, 2021
- Stanford neuroscientist's 'assembloids' pave the way for innovative brain research - Scope - October 2nd, 2021
- At the crossroads of reproductive and regenerative medicine: new opportunities for preserving and restoring fertility - ESHRE - September 25th, 2021
- Doctors Debate: Do CAR T Cells and Transplantation Both Have a Place in Aggressive B-Cell Lymphoma Treatment? - Targeted Oncology - September 25th, 2021
- Global Stem Cell Alopecia Treatment Market 2021 Development Status,Industry Insights and Forecast Research Report 2027 Stillwater Current -... - September 25th, 2021
- AML vs. ALL: Differences in symptoms, diagnosis, and survival - Medical News Today - September 25th, 2021
- New gene therapies may soon treat dozens of rare diseases - American Society for Biochemistry and Molecular Biology - September 25th, 2021
- BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program - GlobeNewswire - September 25th, 2021